Professor Richard Grose
Richard worked for Amersham International for a year, developing ELISAs for HIV testing, before reading Zoology at the University in Bristol in 1991. Having worked at Pfizer Central Research as a Summer Scholar in 1993 with Nicola Worman, he joined the Pfizer Molecular Sciences team in 1994 as a Research Associate, working for Dr Ross Kinloch. In 1995, he joined Prof Paul Martin's Lab at UCL to undertake a PhD on the "Molecular Basis of Embryonic Wound Healing", using mouse and fly models. Upon graduating in 1999, he joined Prof Sabine Werner's lab at ETH-Zurich as a postdoc, where he worked on genetically modified mouse models of cutaneous development and repair. He returned to the UK in 2001 to join Prof Clive Dickson's lab at the Cancer Research UK London Research Institute, where he maintained close collaborations with Prof Werner and developed his interest in FGFR signalling in cancer. In 2004, he joined Prof Ian Hart's Centre for Tumour Biology at Barts Cancer Institute.
Dr Edward Carter
Ed obtained a Masters in Pharmacology from the University of Bath in 2014. He then continued at Bath for his PhD, investigating PI3K signalling in the branching program of the embryonic lung, in the laboratories of Professors Steve Ward and David Tosh, and Dr Malcolm Watson. Ed joined the Grose lab in 2014 where his work currently focuses on developing 3D models and imaging techniques to investigate stromal-led invasion in breast and pancreatic cancer.
E-mail: e.carter@qmul.ac.uk
Dr Lucía Fernández
Lucía obtained her BSc in Pharmacy followed by a MRes in Molecular Approaches in Health Sciences, both from the University of Valencia. She continued there for her PhD in Biomedicine to study how calpains subcellular localization determines their roles in physiological and neoplastic breast models. Lucía joined the Grose lab in 2018 to investigate the crosstalk between luminal and myoepithelial cells in the progression from DCIS to invasive breast cancer.
E-mail: l.fernandez@qmul.ac.uk
Dr Chris Milton
Chris obtained a BSc in Biology from the University of York, which included a placement at AstraZeneca. He worked at Inpharmatica, followed by the National Institute of Medical Research before conducting a PhD on resistance to PI3K inhibitors in Prof Paul Workman’s lab at the ICR. He continued at the ICR in Prof Jane Shipley’s lab studying FGFRs in paediatric sarcomas before joining the Grose lab to investigate mechanisms of FGFR1 controlled invasion in pancreatic cancer.
E-mail: c.milton@qmul.ac.uk
Dr Abigail Wilson
Abi obtained a BSc in Biomedical Science from the University of Surrey in 2013, which included a placement year at GSK. She then obtained an MSc in Cancer Therapeutics at BCI in 2015, before continuing in the labs of Prof Richard Grose and Prof Hemant Kocher for her PhD project focused on targeting FGFR signalling cross-talk in pancreatic cancer. Abi has continued as a postdoc to finish off her PhD work.
E-mail: a.s.coetzee@qmul.ac.uk
Demi Wiskerke
Demi obtained her BSc in Archaeological, Anthropological and Forensic Sciences from Bournemouth University followed by an MRes in Cancer Biology from Imperial College London in 2018, after which she joined the Grose lab. For her PhD, she is investigating how to circumvent resistance to EGFR targeted therapy in glioblastoma.
E-mail: d.a.wiskerke@qmul.ac.uk
Reza Roozitalab
Reza obtained his BSc in Biomedical Sciences followed by an MSc in Cancer and Molecular and Cellular Biology at Queen Mary Univeristy of London. He went onto do an MRes in Translational Immunology (MRC DTP) and is currently developing 3D in vitro models to study how macrophages promote breast cancer progression.
E-mail: m.r.roozitalab@qmul.ac.uk
Nicolas Roth
Nicolas graduated with a BSc in Biochemistry from the University of Essex, which included a year at GlaxoSmithKline. He then spent some time working at Cancer Research UK before joining the MRC DTP, where he is now investigating the use of cannabinoids in combination therapy to treat HER2+ breast cancer.
E-mail: n.roth@qmul.ac.uk
Shayin Gibson
Shayin obtained her BSc in Medical Sciences from the University of Exeter, which included a placement year spent at BCI. She received an MRes in Cancer Biology from Imperial College London before joining the Grose lab in 2019. Her PhD project aims to explore the role of the myoepithelial degradome in breast cancer progression.
E-mail: s.v.gibson@qmul.ac.uk
Elena Tomas Bort
Elena studied Medical Engineering BEng at Queen Mary University of London followed by an MSc in Cancer and Therapeutics at Barts Cancer Institute. For her PhD, Elena is exploring purinergic signalling pathways for the treatment of pancreatic ductal adenocarcinoma.
E-mail: e.tomasbort@qmul.ac.uk